Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001829126-24-007587
Filing Date
2024-11-15
Accepted
2024-11-15 16:10:11
Documents
1
Period of Report
2024-09-30
Effectiveness Date
2024-11-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q titanpharma_nt10q.htm NT 10-Q 17643
  Complete submission text file 0001829126-24-007587.txt   18780
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 241467933
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)